Tecan : J.P. Morgan Healthcare Conference, 14 Jan 2021
January 19, 2021 at 09:38 am EST
Share
Tecan Group
Annual J.P. Morgan Healthcare Conference 2021
ACHIM VON LEOPRECHTING, CEO
JANUARY 14, 2021
Safe Harbor Statement
All statements in this presentation not referring to historical facts are predictions of the future and constitute no guarantee whatsoever of future performances. They are subject to risks and uncertainties including, but not limited to, future global economic conditions, exchange rates, legal regulations, market conditions, activities of competitors and other factors outside the Company's control.
Tecan Group AG is making all efforts to include accurate and up-to-date information into this presentation. Yet, it cannot be ruled out that omissions or errors might have occurred. Therefore, Tecan Group AG cannot make any representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided in this presentation. The Company assumes no obligation to update the information in this presentation. Changes in this presentation can be made any time without notice. All mentioned trademarks are protected by law.
Pioneer and global leader in laboratory automation, in 2020 we celebrated our 40th anniversary
Our solutions accelerate, automate and enhance the processes in state-of-the-art diagnostics and life sciences labs
Adding reagents and consumables to complete automation solutions:
Immunoassays for specialty diagnostics
Functional consumables for MassSpec sample preparation
Reagents and consumables for Genomics NGS library preparation
Innovative digital offering for laboratory management and services
HQ in Switzerland, 3 manufacturing and R&D sites in Europe and
4 in the US, 1 manufacturing site in Asia; software competence center in Germany
~2,000 employees; global sales and service network
Listed at the SIX Swiss Exchange (TECN; TECN SW)
3
Tecan's Products, Business Structure and Markets
LIFE SCIENCES BUSINESS
Focused on all end-user activities
Products marketed under the Tecan brand through own sales & service organizations and distributors
Instruments, reagents, consumables, customer service, spare parts
PARTNERING BUSINESS
Focused on all OEM activities
Products sold by partners under their own brand, partner combines instruments with own reagents/tests
Dedicated systems, platform-based instruments, components, consumables, spare parts, service
57% OF GROUP SALES
43% OF GROUP SALES
CHF 637M IN REVENUE (2019)
LIFE SCIENCE
DIAGNOSTICS
APPLIED
RESEARCH
MARKETS
Fiscal year 2019
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Tecan Group AG published this content on 14 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 January 2021 14:37:08 UTC
Tecan Group AG is a Switzerland-based company engaged in the development, production and distribution of advanced automation and detection solutions for the life science laboratories. Its product portfolio is diversified into several product groups. The Liquid Handling & Robotics group encompasses laboratory technologies for safety, among others. The Reader & Washer product group covers micro plate instruments. The Microarray Products group includes microarray scanner and automated hybridization station. The HP D300 Digital Dispenser and Sample Management product groups cover systems for automated management of sample libraries. The Components group covers the supply services of products for laboratory automation instruments. The OEM (original equipment manufacturing) product group covers platform-based systems, systems from scratch and Cavro OEM Components. The Company also offers packaged software and consumables through Software and Consumables product groups, respectively.
TECAN GROUP AG 
